Results
1 -
10 of
59Cordes Herman F..
Mass spectrometric evidence for the existence of 1,2-dioxetanedione (carbon dioxide dimer). Chemiluminescent intermediate, Journal of the American Chemical Society, 1969 Bos R.
Studies on the mechanism of the peroxyoxalate chemiluminescence reaction Part 1. Confirmation of 1,2-dioxetanedione as an intermediate using 13C nuclear magnetic resonance spectroscopy, Analytica Chimica Acta, 2004 Ji Hoon Lee, James C. Rock, Seung Bum Park, Mark A. Schlautman and Elizabeth R. Carraway.
Study of the characteristics of three high-energy intermediates generated in peroxyoxalate chemiluminescence (PO-CL) reactions, J. Chem. Soc., Perkin Trans. 2, 2002, 0, 802. Ryu Koike, Jiro Motoyoshiya, Yutaka Takaguchi and Hiromu Aoyama.
The key intermediates that interact with the fluorophores in the peroxyoxalate chemiluminescence reaction of 2,4,6-trichlorophenyl N-aryl-N-tosyloxamates, Chem. Commun., 2003, 0, 794. Yoshida T; Akahoshi F; Sakashita H; Shima K; Nabeno M; Abe Y; Anabuki J; Soejima A; Yoshida K; Takashina Y; Ishii S; Kiuchi S; Fukuda S; Kitajima H; Tsutsumiuchi R; Kosaka K; Murozono T; Nakamaru Y; Utsumi H; Masutomi N; Kishida H; Miyaguchi I; Hayashi Y; Nakamura M; Sonda S; Takeuchi M; Tanaka Y; Ueda N; Sekiguchi S; Ishige T.
Discovery and preclinical profile of teneligliptin (3-[(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-ylcarbonyl]thiazolidine): a highly potent, selective, long-lasting and orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes., Bioorganic & medicinal chemistry